• Mashup Score: 0

    This session provides an in depth review of bifurcation disease management. The concept of an up-front two stent strategy is addressed along with a review of the different 2-stent techniques and the role of intracoronary imaging & physiology to guide the decision making.

    Tweet Tweets with this article
    • #SCAI2023 teaser: This #coronary session will provide an in-depth review of #bifurcation disease management including: ✅ 2-stent techniques ✅ Role of #intracoronary imaging and physiology to guide decision-making Learn more ➡️ https://t.co/RzJGqFm8ur https://t.co/eENyMIMNxh

  • Mashup Score: 3

    How to Register To register, press the “Login, Get Started, or Register” button. Sign in with your scai.org username and password. If you don’t have an account, click “Set Up Your Login.” Once registered, you will see a screen where you can add the webinar to your calendar. If you have already registered,…

    Tweet Tweets with this article
    • Have you registered for our first #Bifurcation Club webinar on Procedural Approaches and Techniques for Complex Lesions on March 30? Tell a friend and register today! ➡️ https://t.co/DiIAd5zWSA #CardioTwitter #CardioEd https://t.co/uvmYPMxEdy

  • Mashup Score: 1

    How to Register To register, press the “Login, Get Started, or Register” button. Sign in with your scai.org username and password. If you don’t have an account, click “Set Up Your Login.” Once registered, you will see a screen where you can add the webinar to your calendar. If you have already registered,…

    Tweet Tweets with this article
    • Our first #bifurcation Club webinar will take place on Thursday, March 30. Be sure to add this ABIM MOC and CME-certified event to your calendar! Register for the series ➡️ https://t.co/DiIAd5zWSA https://t.co/VQ7mS3GFPw

  • Mashup Score: 0

    September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the treatment of non-left main bifurcation lesions utilizing the provisional bifurcation stenting technique (using a single stent to treat the bifurcation) with the Onyx Frontier drug-eluting stent (DES) and the Resolute Onyx DES.1 This indication will allow Medtronic to provide a…

    Tweet Tweets with this article
    • @DAICeditor @Medtronic Medtronic received #FDA approval for the treatment of non-left main bifurcation lesions utilizing the provisional #bifurcation #stenting technique with the #OnyxFrontier drug-eluting stent (#DES) and the #ResoluteOnyxDES: https://t.co/0vJIKG2TYB